Information Leaflets

Here you can download any of the five short information leaflets designed for patients and caregivers.

What is ALL? Brochure

This brochure describes Acute Lymphoblastic Leukemia (ALL), includes information about possible signs and symptoms, and the types of treatment available. You can download What is ALL? Leaflet here.

Treatment Factsheet

This factsheet specifically provides details about treatments for ALL. You can download Treatment Factsheet here.

Treatment FAQ Factsheet

This factsheet provides some frequently asked questions about the treatment for ALL and lists other resources for additional information and support. You can download the Treatment FAQ Factsheet here.

Asparaginases Factsheet

This factsheet is designed to give information specifically on asparaginases. Including how asparaginases work, the different types available and why patients may be switched to another type of asparaginase. You can download the Asparaginases Factsheet here.

Erwinaze Leaflet

This leaflet describes important characteristics of Erwinaze (asparaginase Erwinia chrysanthemi) and why patients may be switched to this asparaginase treatment. You can download the Erwinaze Leaflet here.

CONTRAINDICATIONS: Hx of serious hypersensitivity to Erwinaze, including anaphylaxis; Hx of serious pancreatitis, thrombosis or hemorrhage with prior L-asparaginase therapy.

WARNINGS AND PRECAUTIONS: Discontinue if serious hypersensitivity, including anaphylaxis, OR severe or hemorrhagic pancreatitis occur. Monitor glucose (intolerance may not be reversible); With thrombosis and hemorrhage: discontinue until resolved. Use in pregnant women only if clearly needed. Do not use in lactating women.

COMMON (≥ 1%) ADVERSE REACTIONS: Serious hypersensitivity, including anaphylaxis, pancreatitis, abnormal transaminases, coagulation abnormalities, nausea, vomiting, and hyperglycemia.

Please see full Prescribing Information.

This site is only intended for residents of the United States.